Avadel Pharmaceuticals (AVDL) announced the appointment of Susan Rodriguez as COO. In this newly created role, Rodriguez will lead all aspects of the company’s commercial strategy, structure, organization, and related operations, including supply chain.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVDL:
- Avadel Pharmaceuticals Sees Strong Q1 Growth, Raises Guidance
- Avadel Pharmaceuticals’ Earnings Call Highlights Growth and Optimism
- Avadel Pharmaceuticals reports Q1 EPS (5c), consensus (7c)
- Avadel Pharmaceuticals sees FY25 revenue $255M-$265M, consensus $249.16M
- Avadel Pharmaceuticals sees Q2 revenue $60M-$63M, consensus $58.21M
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue